Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 836 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 476.91 USD | -2.22% | -5.56% | -9.93% | +12.58% | 11.02 B USD | ||
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.89 USD | -0.56% | -6.20% | -14.78% | +1.65% | 10.63 B USD | ||
| 865 |  IBRX ImmunityBio, Inc. - Common Stock | 9.91 USD | +1.64% | +5.20% | +25.92% | +302.85% | 10.50 B USD | ||
| 892 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.75 USD | +1.01% | +4.55% | +1.76% | +98.61% | 10.02 B USD | ||
| 909 |  KRYS Krystal Biotech, Inc. - Common Stock | 327.30 USD | +0.84% | +0.17% | -6.18% | +74.91% | 9.69 B USD | ||
| 910 |  PCVX Vaxcyte, Inc. - Common Stock | 65.02 USD | -2.90% | +14.49% | +8.38% | +53.71% | 9.68 B USD | ||
| 941 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 109.30 USD | +0.88% | -1.74% | -5.24% | +84.94% | 9.09 B USD | ||
| 943 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 139.91 USD | -0.72% | -0.77% | -4.20% | +86.22% | 9.05 B USD | ||
| 955 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 170.08 USD | -1.67% | -6.36% | -18.22% | +30.63% | 8.91 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.01 USD | +1.46% | -6.68% | -16.55% | +6.73% | 8.62 B USD | ||
| 973 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 60.74 USD | -1.20% | -6.05% | -28.25% | +55.35% | 8.58 B USD | ||
| 997 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.34 USD | +0.74% | -1.53% | -1.88% | +53.01% | 8.16 B USD | ||
| 1049 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 263.55 USD | -5.20% | -9.16% | -22.39% | +380.40% | 7.36 B USD | ||
| 1058 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 43.30 USD | -1.95% | -1.97% | -23.04% | -39.96% | 7.20 B USD | ||
| 1068 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 79.90 USD | -1.18% | -12.35% | -9.28% | +234.17% | 7.05 B USD | ||
| 1075 |  ABVX Abivax SA - American Depositary Shares | 89.05 USD | +2.34% | -7.07% | -24.41% | -4.76% | 6.99 B USD | ||
| 1145 |  IMVT Immunovant, Inc. - Common Stock | 30.26 USD | -5.56% | -11.26% | -22.63% | +57.52% | 6.25 B USD | ||
| 1151 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.64 USD | +1.35% | -5.61% | -10.63% | -18.74% | 6.17 B USD | ||
| 1167 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 13.31 USD | +3.02% | -7.95% | +59.98% | +507.76% | 6.03 B USD | ||
| 1172 |  BLTE Belite Bio Inc - American Depositary Shares | 152.52 USD | -2.28% | -6.72% | -15.39% | +94.37% | 6.00 B USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |